Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cells

BJU International

Volumn 100, Issue 2, 2007, Pages 445-449

  Long, Ronan M ^a,b   Morrissey, Colm ^a   Walsh, Sinead ^a   Hamilton, Hilary J ^a   Farrell, Nicole ^a   O'Neill, Amanda ^a   Fitzpatrick, John M ^a   Watson, William R ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

Author keywords

Androgen; Differentiation; Epithelial; HPr 1; Prostate; Secretory

Indexed keywords

ANDROSTANOLONE; CYTOKERATIN 14; CYTOKERATIN 18; DNA; INHIBITOR OF APOPTOSIS PROTEIN 1; PROPIDIUM IODIDE; PROTEIN SUBUNIT; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL VIABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL DIFFERENTIATION; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KERATIN-14; KERATIN-18; MALE; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 34447135104     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06932.x     Document Type: Article

References (34)

1. Gronberg H. Prostate cancer epidemiology. Lancet 2003 361 : 859 64
2. Huggins C, Hodges C. Studies on prostate cancer, 1: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941 1 : 293 7
3. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989 2 : 33 50
4. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988 13 : 25 38
5. van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest 2000 80 : 1251 8
6. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR. Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 2001 49 : 271 8
7. Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994 24 : 114 8
8. Huss WJ, Gray DR, Werdin ES, Funkhouser WK Jr, Smith GJ. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate 2004 60 : 77 90
9. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 1990 143 : 167 71
10. Nagle RB, Brawer MK, Kittelson J, Clark V. Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 1991 138 : 119 28
11. Yang Y, Hao J, Liu X, Dalkin B, Nagle RB. Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. Am J Pathol 1997 150 : 693 704
12. Liu AY, True LD, LaTray L et al. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci USA 1997 94 : 10705 10
13. Sherwood ER, Theyer G, Steiner G, Berg LA, Kozlowski JM, Lee C. Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate. Prostate 1991 18 : 303 14
14. Okada H, Tsubura A, Okamura A et al. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol 1992 421 : 157 61
15. Masai M, Sumiya H, Akimoto S et al. Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 1990 17 : 293 300
16. Wernert N, Seitz G, Goebbels R, Dhom G. Immunohistochemical demonstration of cytokeratins in the human prostate. Pathol Res Pract 1986 181 : 668 74
17. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 1987 47 : 281 6
18. McDonnell TJ, Troncoso P, Brisbay SM et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992 52 : 6940 4
19. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991 88 : 6961 5
20. Colombel M, Symmans F, Gil S et al. Detection of the apoptosis- suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 1993 143 : 390 400
21. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994 145 : 1323 36
22. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM. Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 2002 51 : 133 40
23. Krajewska M, Krajewski S, Banares S et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003 9 : 4914 25
24. Choo CK, Ling MT, Chan KW et al. Immortalization of human prostate epithelial cells by HPV 16, E6/E7 open reading frames. Prostate 1999 40 : 150 8
25. Ling MT, Chan KW, Choo CK. Androgen induces differentiation of a human papillomavirus 16, E6/E7 immortalized prostate epithelial cell line. J Endocrinol 2001 170 : 287 96
26. Dixon SC, Soriano BJ, Lush RM, Borner MM, Figg WD. Apoptosis. its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmacother 1997 31 : 76 82
27. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986 83 : 5214 8
28. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988 335 : 440 2
29. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994 124 : 1 6
30. Watson RW, Rotstein OD, Parodo J, Bitar R, Hackam D, Marshall JC. Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression. FEBS Lett 1997 412 : 603 9
31. Santos-Beneit AM, Mollinedo F. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells. J Leukoc Biol 2000 67 : 712 24
32. Doyle BT, O'Neill AJ, Newsholme P, Fitzpatrick JM, Watson RW. The loss of IAP expression during HL-60 cell differentiation is caspase-independent. J Leukoc Biol 2002 71 : 247 54
33. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 1993 67 : 2168 74
34. Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 1994 68 : 2521 8